Cargando…

Quantification of Plasma and Urine Thymidine and 2’-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an ultra-rare disorder caused by mutations in TYMP, leading to a deficiency in thymidine phosphorylase and a subsequent systemic accumulation of thymidine and 2’-deoxyuridine. Erythrocyte-encapsulated thymidine phosphorylase (EE-TP) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kipper, Karin, Hecht, Max, Antunes, Natalicia J., Fairbanks, Lynette D., Levene, Michelle, Kalkan Uçar, Sema, Schaefer, Andrew, Blakely, Emma L., Bax, Bridget E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141342/ https://www.ncbi.nlm.nih.gov/pubmed/32183169 http://dx.doi.org/10.3390/jcm9030788

Ejemplares similares

Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy
por: Levene, Michelle, et al.
Publicado: (2019)

Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial
por: Bax, Bridget E., et al.
Publicado: (2019)

Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
por: Boschetti, Elisa, et al.
Publicado: (2014)

Correction: Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
Publicado: (2014)

Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options
por: Yadak, Rana, et al.
Publicado: (2017)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands
por: Falcão de Campos, Catarina, et al.
Publicado: (2019)

Comment on “Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands”
por: Finsterer, Josef
Publicado: (2021)

Rare pathogenic mutation in the thymidine phosphorylase gene (TYMP) causing mitochondrial neurogastrointestinal encephalomyelopathy
por: Shah, Syed Asfand Yar, et al.
Publicado: (2022)

Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment
por: Bax, Bridget E.
Publicado: (2020)

Clinical spectrum of early onset “Mediterranean” (homozygous p.P131L mutation) mitochondrial neurogastrointestinal encephalomyopathy
por: Kalkan Uçar, Sema, et al.
Publicado: (2022)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far
por: Pacitti, Dario, et al.
Publicado: (2018)

Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes
por: Gautheron, Jérémie, et al.
Publicado: (2022)

Validation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement Therapy
por: Levene, Michelle, et al.
Publicado: (2018)

The cytosol activity of thymidine phosphorylase in endometrial cancer
por: Miszczak-Zaborska, Elżbieta, et al.
Publicado: (2008)

Expression of Thymidine Phosphorylase in Human Gastric Carcinoma
por: Takebayashi, Yuji, et al.
Publicado: (1996)

Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase
por: Harada, Naomoto, et al.
Publicado: (2023)

Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
por: Hata, K, et al.
Publicado: (1999)

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
por: Di Gennaro, E, et al.
Publicado: (2010)

Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1)
por: Filosto, Massimiliano, et al.
Publicado: (2018)

A Rare Case of Mitochondrial Neurogastrointestinal Encephalomyopathy
por: Manski, Scott Adam, et al.
Publicado: (2022)

Mitochondrial Neurogastrointestinal Encephalomyopathy Causing Fanconi Syndrome
por: Razzaq, Ansa, et al.
Publicado: (2022)

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis
por: Marchetti, S, et al.
Publicado: (2001)

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer
por: Toi, M, et al.
Publicado: (2004)

Structures of native human thymidine phosphorylase and in complex with 5-iodouracil
por: Mitsiki, Eirini, et al.
Publicado: (2009)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
por: Lindskog, Elinor B., et al.
Publicado: (2012)

Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome with an Unusual Pattern of Inheritance
por: Trikamji, Bhavesh, et al.
Publicado: (2017)

Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.
por: Patterson, A. V., et al.
Publicado: (1995)

The Expression of Thymidine Phosphorylase in Cancer-infiltrating Inflammatory Cells in Stomach Cancer
por: Jang, Joung Soon, et al.
Publicado: (2007)

Research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
por: Ye, Dian-Jun, et al.
Publicado: (2013)

Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome
por: Bakker, Jaap A., et al.
Publicado: (2010)

Possible role of thymidine phosphorylase in gynecological tumors as an individualized treatment strategy
por: Shida, Masako, et al.
Publicado: (2016)

Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner
por: Li, Wei, et al.
Publicado: (2021)

Mitochondrial Neurogastrointestinal Encephalomyopathy: A Nonrenal Indication for Peritoneal Dialysis
por: Chandra, V. S., et al.
Publicado: (2018)

Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy
por: Habibzadeh, Parham, et al.
Publicado: (2020)

Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome
por: Nie, Xingcao, et al.
Publicado: (2011)

Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer
por: Won, Hye Sung, et al.
Publicado: (2010)

Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer
por: Lindskog, Elinor Bexe, et al.
Publicado: (2014)

4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
por: Tamura, Ryosuke, et al.
Publicado: (2014)

Erratum to research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
por: Ye, Dian-Jun, et al.
Publicado: (2013)

Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase
por: Oh, Taesung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h0p9jj0blnv1urlnisod0ui95j